drugset / Trial / NCT01407107

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

NCT01407107

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether topical nitroglycerin in addition to 5-flourouracil and radiation therapy are effective in the treatment of operable rectal cancer.

Timeline

Start
2011-01
Primary completion
2015-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.2 mg Other
Subject Nitroglycerin Unknown 0.4 mg Other
Subject Nitroglycerin Unknown 0.6 mg Other

Indications